GLP-1 RA antiobesity medications: Talking about cost

Key Takeaways

• GLP-1 receptor agonists are effective for obesity treatment but are associated with high costs, impacting patient access.
• Physicians should engage in transparent discussions with patients about the financial implications of GLP-1 RAs.
• Dr. Robert Kushner highlights the importance of balancing treatment efficacy with affordability and accessibility for patients.
• Experience in research and clinical practice informs strategies for addressing financial barriers in obesity treatment.